|
⚲
|
| Keyboard |
| Luc Dochez | |
|---|---|
| Firm | |
| Address | 1361 Amsterdam Avenue Suite 520 New York, NY 10027 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Volastra Therapeutics Inc | 021-558375 | Director | 30.1 M of 30.1 M |
||
| Quralis Corp | 021-556816 | Director | 20.0 M of 24.9 M |
||
| Quralis Corp | 021-475621 | Director | 60.0 M of 88.0 M |
||
| Volastra Therapeutics Inc | 021-475679 | Director | 60.2 M of 60.2 M |
||
| Quralis Corp | 021-457747 | Director | 5.0 M of 10.0 M |
||
| Summation Bio Inc | 021-440343 | Director | 24.5 M of 64.5 M |
||
| Quralis Corp | 021-367164 | Director | 33.2 M of 60.0 M |
||
| Erytech Pharma Sa | 021-253608 | Director | 4.0 M of 4.0 M |
||
| Prosensa Holding NV | 021-229654 | Executive Officer | 50.5 M of 50.5 M |
||